Products
Introducing
Following the discovery that cinnamon polyphenol fraction (PPF) can assist in neutralizing viruses (see Antiviral Platform), Novid-20 has made significant technological innovations:
- Development of an all-natural full-scale process to extract PPF from raw cinnamon without involving any chemicals.
- Development of an industrial process for production of PPF-enriched, tasty, sugar-free lozenges for consumption as a food supplement.
PPF Features
- Isolated by a physical industrial separation technology (no chemicals)
- A specific, reproducible, unique process
- The specific cinnamon fraction responsible for its antiviral effect was unknown until PPF was characterized and defined by us
- Both the compound and the technological process are patent pending. Patent rights will be pursued globally.
- Stable product – insensitive to elevated temperatures and storage conditions
- PPF is branded Cinnovir
IP
Cinnovir (the active compound), as well as the technology of its production, are proprietary and patent pending (IL277753 & IL283292, PCT/IL2021/051186). Additional patents related to the anti-Herpes and animal applications are under way.
Novid Products
- Product 1 (ready) Cinnovir water extract with 10% active content (polyphenol anti-viral compound produced from cinnamon)
- Product 2 (ready) Cinnovir Lozenges (Sugar-free, appealing lozenges. Sucking a lozenge causes the slow release of the active compound, coating the buccal cavity with this compound)
- Product 3 (ready) Cinnovir cosmetic therapeutic gel (an experimental anti-Herpes gel based on Cinnovir has been formulated)
- Product 4 (R&D) Cinnovir for animal health (Projected to be applicable against:
-
- Avian flu
- Porcine viruses
-
Wrapped Cinnovir Lozenges
Unwrapped Cinnovir Lozenges
Industrial production of Cinnovir has already started.
What We Know
- Cinnovir is an inexpensive, safe, and naturally derived compound, representing only 2.5% of the volume of the cinnamon bark. Its polyphenol content is as much as 90%.
- Cinnovir has a pronounced broad-spectrum antiviral capability.
- Cinnovir & Cinnovir Lozenges do not require refrigeration and can therefore be easily stored, handled and transported to distant locations, including developing countries.
- According to lab studies: Cinnovir and related products are effective against Herpes 1, Covid-19, Influenza and several animal viruses.
What We Hope to Demonstrate
In human studies:
- Cinnovir, Cinnovir lozenges and Cinnovir Gel significantly shorten and alleviate the outbreak of Herpes 1
- Cinnovir, Cinnovir lozenges significantly reduce the viral load and hence can provide an additional protective layer against Covid-19
In animal studies:
- Efficacy of Cinnovir in prevention of Avian Flu, bovine and porcine viral diseases.
Pricing
Anti-Herpes-1 applications
Wholesale price of one 20-lozenge pack (amount needed for one outbreak) is $4.50.
Anti Covid
The projected wholesale price of the recommended daily dose for the individual exposed to Covid-19 (five lozenges) is $0.8. This is a very low-cost solution, affordable to a wide spectrum of households. For prophylactic purposes, consumption, and hence price, can be a fraction of this sum.
Animal applications
- If added to drinking water: $0.001 per day per chicken
- If added to drinking water: $0.01 per day per pig
Regulatory
At present, Cinnovir and lozenges can only be marketed as food supplements.
Investigation is currently under way to determine whether, according to European regulations, Cinnovir can be classified as a “device,” given that the product operates as a barrier and is not involved in biochemical interactions; this would correspond to Class II Approval. Clinical studies related to Herpes 1 are envisaged shortly.
Disclaimer
At present, Cinnovir and Cinnovir lozenges are marketed strictly as nutritional supplements. No explicit or implied medical claims with respect to their potential antiviral activity are made. All content on this website is provided for informational purposes only. The reader is called upon to exercise caution, consult with doctors and other professionals, and make independent educated decisions regarding consumption of Cinnovir and Cinnovir lozenges.
Novid-20 thereby disclaims all responsibility for the efficacy or undesirable side effects of these products. We accept no liability whatsoever for any decision made or action taken or not taken.